Becton, Dickinson and Company (NYSE:BDX) (BDX) is a global medical technology company that develops, manufactures and sells a broad range of medical devices, instrument systems and reagents. BD’s products are used by healthcare institutions, clinical laboratories, life science researchers and the pharmaceutical industry to enable safe, effective delivery of care, specimen collection and diagnostic testing. The company’s operations span multiple business areas focused on medical devices, life sciences research tools and interventional technologies.
BD’s product portfolio includes single-use medical devices such as syringes, needles, needlesafety and injection systems, infusion therapy and medication management solutions, as well as vascular access, urology and oncology devices acquired through its interventional business. In diagnostics and life sciences, the company supplies specimen collection systems, diagnostic instrument platforms, molecular and microbiology testing systems, reagents and consumables, and laboratory automation and analytics tools that support clinical testing and biomedical research.
Founded in 1897 by Maxwell W. Becton and Fairleigh S. Dickinson, BD has grown through organic development and strategic acquisitions to become a multinational supplier to the healthcare sector. A notable expansion of its interventional device capabilities followed the acquisition of C.R. Bard, broadening BD’s offerings in vascular, urology and oncology procedural products. The company is headquartered in New Jersey and operates globally, serving customers across North America, Europe, Asia Pacific, Latin America and other regions through a combination of direct sales and distribution partners.
BD is led by President and Chief Executive Officer Thomas E. Polen, and its organization is structured to support innovation, regulatory compliance and global supply chains that deliver products to hospitals, clinics, research laboratories and life science companies. The company emphasizes product safety, clinician and patient protection, and solutions that support clinical workflows and diagnostic decision-making.
